Prenatal exposure to androgens as a factor of fetal programming La exposición prenatal a andrógenos como factor de reprogramación fetal
Author
dc.contributor.author
Recabarren, Sergio E.
Author
dc.contributor.author
Sir Petermann, Teresa
Author
dc.contributor.author
Maliqueo Yevilao, Manuel
Author
dc.contributor.author
Lobos, Alejandro
Author
dc.contributor.author
Rojas García, Pedro
Admission date
dc.date.accessioned
2019-03-11T12:50:57Z
Available date
dc.date.available
2019-03-11T12:50:57Z
Publication date
dc.date.issued
2006
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 134, Issue 1, 2018, Pages 101-108
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164123
Abstract
dc.description.abstract
Both epidemiological and clinical evidence suggest a relationship between the prenatal environment and the risk of developing diseases during adulthood. The first observations about this relationship showed that prenatal growth retardation or stress conditions during fetal life were associated to cardiovascular, metabolic and other diseases in later life. However, not only those conditions may have lasting effects after birth. Growing evidence suggests that prenatal exposure to steroids (either of fetal or maternal origin) could be another source of prenatal programming with detrimental consequences during adulthood. We have recently demonstrated that pregnant women with polycystic ovary syndrome exhibit elevated androgen levels compared to normal pregnant women, which could provide an androgen excess for both female or male fetuses. We have further tested this hypothesis in an animal model of prenatal androgenization, finding that females born from androgenized mothers have a low birt